Elon Musk's Lawyer Struggles To Find Acceptable Jurors For Lawsuit Because 'So Many People...Hate Him So Much'

A group of former Twitter investors alleges Elon Musk schemed to back out of his $44 billion 2022 acquisition by driving down Twitter's stock through misleading tweets about the deal and bot-accounts; Judge Charles R. Breyer previously found the securities claims plausible and the jury trial is scheduled to begin March 2. Pretrial jury selection proved contentious — from a pool of 92, roughly 40% were excused for bias against Musk — and Musk's counsel warned that widespread animus complicated seating an impartial jury. The outcome could influence investor sentiment around Musk-linked assets, but immediate market impact is uncertain pending trial findings and potential damages.

Analysis

Market structure: The immediate winners are large ad‑platform incumbents (META, SNAP) that can pick up share if X loses advertiser trust; allocate a 1–3% flow shift over 3–6 months as advertisers reallocate. Direct losers are high‑beta, founder‑centric equities — primarily TSLA — via sentiment-driven flows, not fundamentals; expect 3–8% episodic moves around trial milestones rather than permanent demand destruction.

Risk assessment: Tail scenarios range from immaterial civil damages (<$500m, market muted) to disruptive outcomes (>$3–5bn judgment or SEC enforcement) that could force asset sales or margin pressure on Musk-controlled equity pledges; model a 10–20% downside to TSLA in worst case within 30–90 days. Key short horizons: immediate (days around March 2), short (0–3 months while jury deliberates), long (6–24 months if regulatory follow‑ups occur).

Trade implications: Hedge concentrated TSLA exposure with 60–120 day put spreads (buy 10% OTM put, sell 20% OTM put) sized to cover 1–3% portfolio risk; add 1–3% long positions in META and SNAP for ad reallocation. If IV gaps >6‑8pt above realized vol, consider selling 30‑day TSLA straddles for premium capture; otherwise buy protection pretrial.

Contrarian angles: Consensus overstates reputational spillover — Tesla’s EV demand and FCF are primary drivers and may reassert within 3–6 months; a disciplined event‑driven hedging approach (time‑limited options) captures downside while allowing participation if fundamentals reassert. Watch for overpricing of perpetual CEO‑risk — use short‑dated vol sales once IV normalizes after the initial headline shock.

Key Decisions for Investors

• Establish a 1–2% portfolio hedge on TSLA (ticker: TSLA) by buying a 90‑day 10% OTM put sized to cover 1–2% portfolio loss and sell a 20% OTM put to fund ~30–50% of cost (risk-defined put spread).
• Initiate a 1–3% long position in META and/or SNAP (META, SNAP) to capture 3–6 month ad‑dollar reallocation; scale in over March if X advertising pauses are reported or if CPMs for META/SNAP rise >5% QoQ.
• If TSLA implied vol spikes >8 percentage points above 60‑day realized vol post‑March‑2, sell 30‑day ATM straddles sized to 0.5–1% portfolio exposure to monetize transitory IV; close within 7–14 days or after IV mean‑reversion.
• Reduce concentrated founder‑risk exposure (TSLA and similar single‑founder names) by 20–40% over next 30 days and reallocate proceeds to diversified large‑caps or the above ad‑platform longs; reassess after 60–90 days based on trial developments.
• Monitor three binary catalysts over next 30–90 days: (1) judge rulings on admissible evidence (affects case severity), (2) any SEC/DOJ notification (would materially raise tail), and (3) temporary advertiser flight from X (measurable via ad CPM or reported spend cuts); take incremental actions if any occur.